KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Gains from Investment Securities (2016 - 2026)

AbbVie has reported Gains from Investment Securities over the past 14 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly Gains from Investment Securities rose 129.88% to $1.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.2 billion through Dec 2025, up 2851.32% year-over-year, with the annual reading at $5.2 billion for FY2025, 2851.32% up from the prior year.
  • Gains from Investment Securities was $1.1 billion for Q4 2025 at AbbVie, down from $4.2 billion in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $4.2 billion in Q3 2025 and troughed at -$3.7 billion in Q4 2024.
  • The 5-year median for Gains from Investment Securities is $194.0 million (2021), against an average of $453.2 million.
  • Year-over-year, Gains from Investment Securities tumbled 654.68% in 2022 and then surged 5245.65% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $2.6 billion in 2021, then crashed by 64.8% to $919.0 million in 2022, then increased by 9.25% to $1.0 billion in 2023, then tumbled by 466.63% to -$3.7 billion in 2024, then skyrocketed by 129.88% to $1.1 billion in 2025.
  • Per Business Quant, the three most recent readings for ABBV's Gains from Investment Securities are $1.1 billion (Q4 2025), $4.2 billion (Q3 2025), and -$79.0 million (Q2 2025).